72 results
424B4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
11 Dec 20
Prospectus supplement with pricing info
12:00am
for a randomized, double blind, parallel group study at a single clinical site in the U.S. The Phase I study evaluated the safety of Trappsol® Cyclo™ … . Enrollment in this study was completed in October 2019, and in May 2020 we announced Top Line data showing a favorable safety and tolerability profile
424B4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
11 Dec 20
Prospectus supplement with pricing info
1:38pm
for a randomized, double blind, parallel group study at a single clinical site in the U.S. The Phase I study evaluated the safety of Trappsol® Cyclo™ … . Enrollment in this study was completed in October 2019, and in May 2020 we announced Top Line data showing a favorable safety and tolerability profile
424B5
d52wp3
16 Aug 21
Prospectus supplement for primary offering
4:33pm
424B5
u49mjwv7v jt32f
18 Nov 21
Prospectus supplement for primary offering
4:31pm
424B5
uvp5e
16 Nov 21
Prospectus supplement for primary offering
4:36pm